Cost-effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy-resistant depression at secondary mental health care settings

Sado M, Koreki A, Ninomiya A, Kurata C, Mitsuda D, Sato Y, Kikuchi T, Fujisawa D, Ono Y, Mimura M, Nakagawa A.

Psychiatry Clin Neurosci. 2021 Nov;75(11):341-350. doi: 10.1111/pcn.13298. Epub 2021 Sep 17.